Literature DB >> 8891339

Suppression of tumorigenicity in Ras-transformed fibroblasts by alpha 2(I) collagen.

H Travers1, N S French, J D Norton.   

Abstract

Transformed fibroblasts exhibit reduced adhesion to substrata, a characteristic attributable in part to reduced expression/increased degradation of extracellular matrix (EM) proteins such as type I collagen. To directly assess the role of EM proteins in cellular transformation, a vKRas-transformed mouse fibroblast cell line was transfected with an alpha 2(I) collagen expression construct. Stable transfectants displaying a partial restoration of type I collagen expression showed a flatter morphology with increased adherence to the substratum. These clones also exhibited a reduced ability to clone in soft agar, slower growth kinetics, and suppression of tumorigenicity in nude mice. Restoration of type I collagen is correlated with down-regulation of ras oncogene-responsive NVL3 VL30 gene expression. These results suggest that in addition to suppressing tumorigenicity by promoting cellular adhesion and cytoskeletal organization, EM proteins such as type I collagen may also act to subvert oncoprotein signaling pathways associated with the malignant phenotype.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8891339

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  5 in total

1.  Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases.

Authors:  M Santra; D M Mann; E W Mercer; T Skorski; B Calabretta; R V Iozzo
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

2.  Genomewide trapping of genes that encode secreted and transmembrane proteins repressed by oncogenic signaling.

Authors:  M Gebauer; H von Melchner; T Beckers
Journal:  Genome Res       Date:  2001-11       Impact factor: 9.043

3.  Global analysis of the medulloblastoma epigenome identifies disease-subgroup-specific inactivation of COL1A2.

Authors:  Jennifer A Anderton; Janet C Lindsey; Meryl E Lusher; Richard J Gilbertson; Simon Bailey; David W Ellison; Steven C Clifford
Journal:  Neuro Oncol       Date:  2008-07-29       Impact factor: 12.300

4.  CDO: an oncogene-, serum-, and anchorage-regulated member of the Ig/fibronectin type III repeat family.

Authors:  J S Kang; M Gao; J L Feinleib; P D Cotter; S N Guadagno; R S Krauss
Journal:  J Cell Biol       Date:  1997-07-14       Impact factor: 10.539

5.  Microarray analysis of gene-expression profiles in diffuse large B-cell lymphoma: identification of genes related to disease progression.

Authors:  Mieko Nishiu; Rempei Yanagawa; Shin-ichi Nakatsuka; Masayuki Yao; Tatsuhiko Tsunoda; Yusuke Nakamura; Katsuyuki Aozasa
Journal:  Jpn J Cancer Res       Date:  2002-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.